1) Vasen HF, Watson P, Mecklin JP, et al : New clinical criteria for hereditary nonpolyposis colorectal cancer(HNPCC, Lynch syndrome)proposed by the International Collaborative group on HNPCC. Gastroenterology 116 : 1453─1456, 1999
2) Boland CR, Thibodeau SN, Hamilton SR, et al : A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition : development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res 58 : 5248─5257, 1998
3) Miki Y, Swensen J, Shattuck─Eidens D, et al : A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266 : 66─71, 1994
4) Wooster R, Bignell G, Lancaster J, et al : Identification of the breast cancer susceptibility gene BRCA2. Nature 378 : 789─792, 1995
5) 野水 整,土屋敦雄,渡辺文明,他 : 家族性乳癌(阿部力哉編).pp7─16,篠原出版,東京,1996
6) Arai M, Utsunomiya J, Miki Y : Familial breast and ovarian cancers. Int J Clin Oncol 9 : 270─282, 2004
7) Slamon DJ, Godolphin W, Jones LA, et al : Studies of the HER─2/neu proto─oncogene in human breast and ovarian cancer. Science 244 : 707─712, 1989
8) Inomata M, Uchino S, Tanimura H, et al : Amplification and overexpression of cyclin D1 in aggressive human esophageal cancer. Oncol Rep 5 : 171─176, 1998
9) Shen DW, Fojo A, Chin JE, et al : Human multidrug─resistant cell lines : increased mdr1 expression can precede gene amplification. Science 232 : 643─645, 1986
10) Seeger RC, Brodeur GM, Sather H, et al : Association of multiple copies of the N─MYC oncogene with rapid progression of neuroblastomas. N Engl J Med 313 : 1111─1116, 1985
11) Shayesteh L, Lu Y, Kuo WL, et al : PIK3CA is implicated as an oncogene in ovarian cancer. Nature Genet 21 : 99─102, 1999
12) Hirasawa A, Saito─Ohara F, Inoue J, et al : Association of 17q21─q24 gain in ovarian clear cell adenocarcinomas with poor prognosis and identification of PPM1D and APPBP2 as likely amplification targets. Clin Cancer Res 9 : 1995─2004, 2003
13) Tsuda H, Bandera CA, Birrer MJ, et al : Cyclin E amplification and overexpression in clear cell adenocarcinoma of the ovary. Oncology 67 : 291─299, 2004
14) Inazawa J, Inoue J, Imoto I : Comparative genomic hybridization(CGH)─ arrays pave the way for identification of novel cancer─related genes. Cancer Sci 95 : 559─563, 2004
15) Slamon DJ, Leyland─Jones B, Shak S, et al : Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. N Engl J Med 344 : 783─792, 2001
16) Tuma RS : Trastuzumab trials steal show at ASCO meeting. J Natl Cancer Inst 97 : 870─871, 2005